Related Experiment Video
Updated: May 13, 2025
07:54
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.1K
Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer Detection
Eunyong Ahn1, Se Ik Kim2, Sungmin Park1
1Foretell My Health, Inc., 558 Handong-ro Buk-gu, Pohang 37554, Republic of Korea.
Cancers
|April 14, 2025
Summary
A new qPCR algorithm using platelet RNA shows promise for early ovarian cancer (OC) detection. This accessible method achieved high sensitivity and specificity, offering a potential breakthrough for diagnosing this lethal gynecologic malignancy.
Area of Science:
- Gynecologic Oncology
- Molecular Diagnostics
- Biomarker Discovery
Background:
- Ovarian cancer (OC) is a leading cause of cancer death among women, with early detection being critical for improved outcomes.
- Current screening methods face limitations in sensitivity and specificity, and advanced techniques like next-generation sequencing (NGS) are often cost-prohibitive for widespread use.
- High-grade serous ovarian cancer (HGSOC) represents the most aggressive subtype, necessitating targeted diagnostic strategies.
Purpose of the Study:
- To develop an accessible and cost-effective diagnostic algorithm for early ovarian cancer detection.
- To identify and validate splice junction-based biomarkers in peripheral blood for distinguishing OC from benign conditions.
- To focus on improving the detection of high-grade serous ovarian cancer (HGSOC).
Main Methods:
- RNA sequencing was employed on peripheral blood samples from OC patients, benign tumor patients, and healthy controls to identify potential splice junction biomarkers.
- A panel of 10 candidate markers was selected based on differential expression patterns.
- Quantitative Polymerase Chain Reaction (qPCR) was used to validate the expression of these markers and develop a classification algorithm.
Main Results:
- The qPCR validation showed strong correlation with RNA sequencing data (R² = 0.44-0.98) for the 10 selected markers.
- The developed classification algorithm demonstrated high diagnostic performance, achieving 94.1% sensitivity and 94.4% specificity.
- The algorithm's effectiveness was further supported by an Area Under the Curve (AUC) of 0.933.
Conclusions:
- Platelet RNA profiling offers a promising avenue for developing a highly specific and accessible early detection method for ovarian cancer.
- The qPCR-based algorithm presents a viable, cost-effective alternative for large-scale screening compared to NGS.
- Further research is warranted to expand the biomarker panel and include diverse histologic subtypes to enhance diagnostic accuracy.
